Recommendations on the diagnosis and treatment of anti-neutrophil cytoplasmic antibody associated vasculitis in China
10.3760/cma.j.cn112138-20220318-00191
- VernacularTitle:抗中性粒细胞胞质抗体相关血管炎诊疗规范
- Author:
Xinping TIAN
1
;
Like ZHAO
;
Zhenyu JIANG
;
Yan WANG
;
Cibo HUANG
;
Yan ZHAO
Author Information
1. 中国医学科学院 北京协和医学院 北京协和医院风湿免疫科 国家皮肤与免疫疾病临床医学研究中心 疑难重症及罕见病国家重点实验室 风湿免疫病学教育部重点实验室，北京 100730
- Keywords:
Anti-neutrophil cytoplasmic antibody associated vasculitis;
Diagnosis;
Treatment
- From:
Chinese Journal of Internal Medicine
2022;61(10):1128-1135
- CountryChina
- Language:Chinese
-
Abstract:
Anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is a group of systemic small vasculitis characterized by ANCA positive in serum. Three diseases are included in this group of diseases: granulomatosis with polyangiitis (GPA), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA). In China, standardized diagnosis and treatment of AAV is still lacking. Based on the evidence and guidelines from China and abroad, the Chinese Rheumatology Association formulated the standardization of diagnosis and treatment of ANCA associated vasculitis. The purpose is to standardize the diagnosis of AAV and disease activity assessment, and recommend the treatment strategies.
